Creating Breakthroughs with Flexibility

Exciting and potentially life-saving discoveries are being developed every day in cancer research laboratories around the world. However, scientific discoveries coming out of research laboratories will not benefit cancer patients without a process of “translation.” “Translational Research” focuses on bridging the gap between laboratory discoveries and patient care. The Fellows Program was initiated to strengthen our efforts in translational research. This program is currently providing long-term and flexible funding to ten NFCR Fellows who are leaders in their respective research fields with close connections to research hospitals. This unique funding approach enables NFCR Fellows to perform innovative research in the laboratories and collaborate with clinicians in the hospitals to convert the potential life-saving discoveries into actual applications to benefit cancer patients.

NFCR Fellows are distinguished and well-established scientists with excellent track records in their individual fields of scientific interest. Throughout the years, our Fellows have demonstrated their dedicated support of NFCR’s mission, and NFCR provides them with long-term research support to allow the nurturing of their discovery-oriented research.

	Webster Cavenee, Ph.D. Ludwig Institute for Cancer Research San Diego, California
	Yung-Chi Cheng, Ph.D. Yale University School of Medicine New Haven, Connecticut
	Curt I. Civin, M.D. Johns Hopkins University Baltimore, Maryland
	Stanley N. Cohen, M.D. Stanford University School of Medicine Stanford, California
	Harold F. Dvorak, M.D. Beth Israel Deaconess Medical Center Boston, Massachusetts
	Waun Ki Hong, M.D. M.D. Anderson Cancer Center Houston, Texas
	Susan Band Horwitz, Ph.D. Albert Einstein College of Medicine Bronx, New York
	Paul Schimmel, Ph.D. The Scripps Research Institute La Jolla, California
	Helmut Sies, M.D. Heinrich-Heine-Universitat Dusseldorf, Germany
	I. Bernard Weinstein, M.D. Columbia University New York, New York